Product Catalog
Blends
Protocols
Explore Our Products
All orders ship same day from our US facility.
Made in the USA
Peptides are precision-synthesized and lyophilized at state-of-the-art laboratories in the United States.
Frequently Asked Questions
Peptides are short chains of amino acids that occur naturally in organisms, where they act as messengers in many biological systems. While some peptides have been developed for medical use, laboratory research focuses on understanding their activity at the cellular level, examining how they impact essential processes in vitro.
Products from Direct Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Orders are typically processed and shipped within 24 hours on weekdays. Delivery times vary by location, but most domestic orders arrive within 3–5 business days. You’ll receive tracking information as soon as your order ships.
Reta
What Is Retatrutide?
Retatrutide, also known as GLP3-R, is an investigational peptide studied for its ability to interact with three key metabolic receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.
In laboratory, preclinical, and controlled clinical research settings, retatrutide is examined for its role in cellular metabolic signaling, insulin sensitivity pathways, and energy-regulation mechanisms, offering insight into integrated metabolic control.
Certificate of Analysis
Third-party tested for 99% purity
GLP3-R Overview
GLP3-R (retatrutide) is a synthetic triple-receptor agonist designed to simultaneously engage GLP-1, GIP, and glucagon signaling pathways. Unlike single- or dual-agonist peptides, retatrutide is investigated for its ability to influence multiple metabolic systems concurrently.
Research explores its relevance to:
- Glucose metabolism
- Energy balance
- Lipid regulation
- Endocrine signaling integration
By activating incretin and glucagon receptors together, retatrutide demonstrates broad biological activity that is of significant interest in metabolic and endocrine research. Its multi-pathway engagement represents a next-generation approach to studying comprehensive metabolic modulation.
Jastreboff A.M. et al., 2023History and Development
The development of GLP3-R builds upon decades of incretin-based metabolic research. Early studies on GLP-1 receptor agonists established their importance in glucose homeostasis and appetite signaling. This work expanded into dual-agonist compounds targeting GLP-1 and GIP, such as tirzepatide.
Retatrutide represents a further evolution of this research by integrating GLP-1, GIP, and glucagon receptor activity into a single molecule. This triple-agonist design reflects growing scientific interest in studying integrated, multi-hormonal metabolic regulation, rather than isolated receptor pathways.
Coskun T. et al., 2022Retatrutide Structure
Research Findings
GLP3-R (retatrutide) has been evaluated across a range of metabolic, endocrine, cardiovascular, and systemic research models. Published studies highlight its influence on insulin signaling pathways, lipid metabolism, energy regulation, and integrated hormonal communication.
Key Areas of Investigation
- Metabolic: Glucose regulation, insulin sensitivity, energy balance
- Endocrine: GLP-1, GIP, and glucagon pathway signaling
- Cardiovascular: Lipid metabolism, cholesterol dynamics, hepatic signaling
- Systemic: Multi-hormone integration, metabolic resilience, signaling balance
Collectively, these findings suggest that retatrutide offers broad experimental utility across metabolic, cardiovascular, and systemic research models. Its ability to engage multiple hormonal pathways simultaneously makes it a versatile platform for studying complex metabolic regulation and integrated physiological signaling.
Jastreboff A.M. et al., New England Journal of Medicine, 2023
